You are here:
NICE
NICE Guidance
Published Guidance
The clinical effectiveness and cost effectiveness of sibutramine for obesity
Technology appraisal guidance
Reference number:
TA31
Published:
28 October 2001
This guidance has been replaced by
NICE guideline CG43
.